Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good point on the other income and I agree that comps will be tougher this year with the normal tax rate.
Also driving the stock price were 2 pieces on ZYXI that came out on SeekingAlpha today.
First was this one
https://seekingalpha.com/instablog/498952-bret-jensen/5299098-4-biotech-stocks-analysts-say-buy-wednesday
Looks like this might be accounting for a little extra push today. He is targeting $9
https://seekingalpha.com/instablog/498952-bret-jensen/5299098-4-biotech-stocks-analysts-say-buy-wednesday
Good results. 34% Revenue increase. 81% gross margins staying the same. Now they will be hiring reps even faster this year - at a pace of 10 per month. A questioner asked how much of the gap left by the previous competitor has been reclaimed and Sandgaard said in the 10s of millions not in the 100s of millions that was left. They are tentatively looking at some acquisitions in a complementary space. He said they have a great training process now for new reps, and the new marketing materials are just about to be deployed to the sales reps. He also mentioned that they could be included in the Russell 2000 soon. They continue to have some clinical studies to prove the efficacy of their new blood volume monitor.
I think the stock continues to look good. They are really building out a strong salesforce and I think they could continue to grow even after fully filling the void from the previous competitor by acquiring other complementary products.
This is their weakest quarter and they still improved 4% over last quarter.
I hope so
It looks like the heavy buying was right after the stock returned to $5. Probably because many funds cannot own stocks valued at less than $5. Also, the volume has been slowing down recently after that, which is what you would expect from the handle in a cup and handle. It should also drift down a bit before the breakout.
Thanks for the link. Strong move today.
Sandgaard said "We believe this initiative puts us in a strong position to procure prescriptions from more prescribing physicians and therefore help accelerate order growth."
So maybe they found that many physicians would n't prescribe their product unless they also accepted Medicare. Seems like good news. It will probably take forever to get Medicare to spice a machine purchase, but at least consumables should hit the income statement right away. And maybe their leasing policy will also help them bill Medicare.
DGSE getting some recent big volume coming in. I don't see any news. Maybe high expectations for this holiday earnings report?
I did not grab any on the dip. I was expecting a larger pop on top line growth thinking it deserved a higher PE on the NASDAQ. They only recently moved to the NASDAQ. And I thought there would still be some mutual funds buying who could not buy before, but maybe they wanted to see continued growth which was there. They will have a tougher time increasing on earnings now that their NOLs are completely out. But they still have easy predictable growth for a few years taking the market share from the big player that left the market. And they are trying to get FDA and CE marking approval on their blood volume monitor. Also their orders have been growing at 30% and this quarter that increased to 35% with their aggressive sales person growth. Q1 weaker because of unmet deductibles at the beginning of the year and doctor vacations, so I guess near-term expectations won't be that high.
ZYXI ($5.40) beat their guidance on revenue up 15% yoy for the quarter 36% yoy for the year. EBITDA came in at low end of their guidance because they have been aggressively increasing salesforce.
http://zynexmed.investorroom.com/2019-02-26-Zynex-Announces-2018-Fourth-Quarter-and-Full-Year-Earnings
Zynex Announces 2018 Fourth Quarter and Full Year Earnings
2018 Full Year
- Revenue increased 36% year over year to $31.9 million
- Net income increased 30% to $9.6 million; Diluted EPS $0.28
- Adjusted EBITDA $10.9M
2018 Fourth Quarter
- Revenue increased 15% year over year to $9.3 million
- Net income of $2.6 million; Diluted EPS $0.08
- Adjusted EBITDA $3.1 million
- Tenth consecutive quarter of positive net income
Listed on The Nasdaq Capital Market effective February 12, 2019
Ya, we are getting a lot more volume and liquidity here on the NASDAQ I noticed the volume is four times the otc volume. And the volume after the bell ringing yesterday was twice the volume that it was before the bell ringing. Today it looks like the volume is even higher, so we are getting some follow through from that exposure.
When there is a gap it usually comes back down at some point to get filled. I'm glad it was filled. I'm just interested in the daily squiggles right now.
Filled
Intraday gap on the chart.
A good start to the day. Volume looks higher today so far.
It bothers me that it is after the bell.
More nice stock action today
I like the stock action today. Looks like the recent sellers might finally be out of stock.
Where have you gone otcbargains?
It's here 14% revenue increase. Big drop in net income of .01 versus .04 net income last year.
https://www.otcmarkets.com/stock/IVFH/news/Innovative-Food-Holdings-Reports-Second-Quarter-2018-Financial-Results?id=200992
Looks like the ITCC quarter came in low at only .01 versus .04 last year in net income.
Hoping for a rally tomorrow. Not final, but seems to have failed by a decent margin.
"The measure currently has only 42 percent of the vote with no signs of increasing."
https://www.9news.com/article/news/local/local-politics/prop-112-fails-buffer-zone-for-oil-and-gas-development-will-not-expand-to-2500-feet/73-611990046
I don't think we'll know how good the iGourmet purchase is until we see the 4th Quarter results.
Saw Capstone 3 motion sensor lights for $20.00 product at Costco
Looks like the stock got a pop today on the news. I think internal bleeding is a big problem in that it is non-obvious to diagnose so an easy to use non-invasive product would seem valuable.
IVFH .69 - Looks like the good market reaction is continuing. Some welcome relief from those lows.
Looks like volatility has returned to ZYXI. I bought some today.
That happened to me also through TDA. I called to place my order. They gave me the web rate and also gave me 10 free trades after I asked them why it was restricted.
I also bought some today. Seems cheap given the growth. Has the recent profitability inflection. The Sony deal looks great to drive growth going forward.
Here are some stocks I purchased recently FWIW.
OPXS - Optex Systems Holdings, Inc - Price $1.515 - TTM P/E of 3.6 on Yahoo. They have a monopoly on making periscopes for the military. They also recently began selling some sort of periscope product
commercially for guns. Latest quarter grew revenue at 42%. Backlog was up 24%. Net income was $.6M annualized gives Price/Annualized Net Income of like 5. Also pays a dividend. Announced 500K share repurchase last month which should catalyze the price to move up.
ESOA - Energy Services of America Corporation - Price of $1.13 - TTM P/E of 35 on Yahoo. Diluted earnings per share of $.058, gives an annualized P/E of 4.9 Energy services company. They do contract work for energy companies in the U.S. They had a bad year in 2017 when rain messed up the scheduling of their projects, they couldn't get qualified labor, and they had to take the hit for all that. They implemented better estimation processes. They announced a share repurchase program that started Aug 15 not to exceed 10% of the outstanding shares which should catalyze some price movement. CEO continually buys a little bit of stock here and there to add to his already large position.
QBAK - Qualstar Corporation - Price $8.17 - TTM P/E of 10.7 on Yahoo - Net income of $.23 per share in most recent quarter. Price/Annualized Net Income = 8.8 with YoY revenue growth of 40%. They make tape drives and high efficiency power supplies. They inked a deal with Sony in the last year to make an optical disk drive that has mechanisms to swap the disks out. Sony created this 3 Terabyte optical disk technology jointly with Panasonic. Qualstar has a long history building tape drives and has the tech to do a good job building this product for Sony. The power supplies are expensive, but I think there must be a market in data centers with servers that are on all time. It is desirable to lower electric bills with highly efficient but reliable power supplies in data centers. With the overwhelming use of data these days we still need tons of space for backups. So I think there is still a market for their product, and near-term I think the Sony deal should continue their growth. They weren't doing well, then in 2013 they began to be turned around. Now they are looking cheap.
This stock is full of surprises, so maybe it will get to $4. I'm not sure to what we owe this move.
I wasn't expecting the jump up this soon after after earnings were released and the market received it in such a ho-hum way. Alot of shares traded hands around the $3.00 level.
Ya, nice move today.
PCHM 1.49 +.24 Are you still holding KiK? Looks like your "non-investible" company is doing alright.
I looked at ITCC. Net Receivables the last 4 quarters $3.4M $1.5M $2.6M $2.2M
Receivables have gone from $1.5M last quarter to $3.4M this quarter and SGA and cost of revenues has gone up some. So it looks like last quarter they had reduced their receivables, causing an increase in income. This quarter they did more business, causing SGA and cost of revenues to rise, and they have billed that causing receivables to be higher than they have been in the last 4 quarters, but the clients haven't paid yet, depressing this quarters net income. So I am expecting next quarter to be good. Let me know if you see something different.
Thanks for the alert.
(PROM, .10) I hope you're right about the good quarter. Ouch!!